Neurological management of fulminant hepatic failure

Neurocritical Care

Volumn 14, Issue 2, 2011, Pages 318-327

  Frontera, Jennifer A ^a   Kalb, Thomas ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acute liver failure; Coagulopathy; Fulminant liver failure; Intracranial pressure

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 7A; ISONIAZID; LACTULOSE; MANNITOL; PARACETAMOL; PROTHROMBIN COMPLEX; PYRAZINAMIDE; SODIUM CHLORIDE; VALPROIC ACID; VITAMIN K GROUP;

ACUTE LIVER FAILURE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS HEMOFILTRATION; DIAGNOSTIC TEST; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE TITRATION; FULMINANT HEPATIC FAILURE; HEPATIC ENCEPHALOPATHY; HUMAN; INTRACRANIAL PRESSURE; LIVER FAILURE; LIVER TRANSPLANTATION; LOADING DRUG DOSE; NEUROLOGIC DISEASE; PATIENT MONITORING; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY CARE; REVIEW; SEDATION; SEIZURE; TREATMENT PLANNING;

HEPATIC ENCEPHALOPATHY; HUMANS; INTENSIVE CARE; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION;

EID: 79955826784     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-010-9470-y     Document Type: Review

References (73)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282-98.
2. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342(8866):273-5. (Pubitemid 23224421)
3. Lee WM. Acute liver failure. N Engl J Med. 1993;329(25): 1862-72.
4. Nourjah P, Ahmad SR, Karwoski C, et al. Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 2006;15(6):398-405. (Pubitemid 44018697)
5. Estes JD, Stolpman D, Olyaei A, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg. 2003;138(8):852-8. (Pubitemid 36960946)
6. Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology. 2006;44(4):788-94. (Pubitemid 46489541)
7. Larsen FS, Gottstein J, Blei AT. Cerebral hyperemia and nitric oxide synthase in rats with ammonia-induced brain edema. J Hepatol. 2001;34(4):548-54. (Pubitemid 32328511)
8. Larsen FS, Ejlersen E, Strauss G, et al. Cerebrovascular metabolic autoregulation is impaired during liver transplantation. Transplantation. 1999;68(10):1472-6.
9. Larsen FS, Knudsen GM, Hansen BA. Pathophysiological changes in cerebral circulation, oxidative metabolism and blood-brain barrier in patients with acute liver failure. Tailored cerebral oxygen utilization. J Hepatol. 1997;27(1):231-8. (Pubitemid 27357082)
10. Strauss G, Hansen BA, Kirkegaard P, et al. Liver function, cerebral blood flow autoregulation, and hepatic encephalopathy in fulminant hepatic failure. Hepatology. 1997;25(4):837-9. (Pubitemid 27157123)
11. Jalan R, Olde Damink SW, Hayes PC, et al. Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol. 2004;41(4):613-20. (Pubitemid 39297797)
12. Jalan R. Intracranial hypertension in acute liver failure: pathophysiological basis of rational management. Semin Liver Dis. 2003;23(3):271-82. (Pubitemid 37052452)
13. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947-54. (Pubitemid 35440240)
14. Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the US. Acute liver failure study group. Crit Care Med. 2007;35(11): 2498-508. (Pubitemid 351339009)
15. Lidofsky SD, Bass NM, Prager MC, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. 1992;16(1):1-7.
16. Munoz SJ, Robinson M, Northrup B, et al. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology. 1991;13(2):209-12.
17. Serocki G, Bein B, Scholz J, et al. Management of the predicted difficult airway: a comparison of conventional blade laryngoscopy with video-assisted blade laryngoscopy and the GlideScope. Eur J Anaesthesiol. 2010;27(1):24-30.
18. Nouruzi-Sedeh P, Schumann M, Groeben H. Laryngoscopy via Macintosh blade versus GlideScope: success rate and time for endotracheal intubation in untrained medical personnel. Anesthesiology. 2009;110(1):32-7.
19. McGuire G, Crossley D, Richards J, et al. Effects of varying levels of positive end-expiratory pressure on intracranial pressure and cerebral perfusion pressure. Crit Care Med. 1997;25(6): 1059-62. (Pubitemid 27264253)
20. Wright RA. Lactulose-induced megacolon. Gastrointest Endosc. 1988;34(6):489-90. (Pubitemid 19007652)
21. Greenberg LH, Momary H. Audiotoxicity and nephrotoxicity due to orally administered neomycin. JAMA. 1965;194(7):827-8.
22. Raschke RA, Curry SC, Rempe S, et al. Results of a protocol for the management of patients with fulminant liver failure. Crit Care Med. 2008;36(8):2244-8.
23. Ede RJ, Gimson AE, Bihari D, et al. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol. 1986;2(1):43-51. (Pubitemid 16177385)
24. Keays RT, Alexander GJ, Williams R. The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. J Hepatol. 1993;18(2):205-9. (Pubitemid 23246947)
25. Blei AT, Olafsson S, Webster S, et al. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet. 1993;341(8838):157-8. (Pubitemid 23029318)
26. Bacher A. Intracranial hypertension in fulminant hepatic failure. Transplant Proc. 2006;38(3):783-5.
27. Fernandes HM, Bingham K, Chambers IR, et al. Clinical evaluation of the Codman microsensor intracranial pressure monitoring system. Acta Neurochir Suppl. 1998;71:44-6. (Pubitemid 128444353)
28. Gray WP, Palmer JD, Gill J, et al. A clinical study of parenchymal and subdural miniature strain-gauge transducers for monitoring intracranial pressure. Neurosurgery. 1996;39(5):927-31. discussion 931-922.
29. Figaji AA, Zwane E, Fieggen AG, et al. Transcranial Doppler pulsatility index is not a reliable indicator of intracranial pressure in children with severe traumatic brain injury. Surg Neurol. 2009; 72(4):389-94.
30. Jeffers L, Chalasani N, Balart L, et al. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology. 2002;123(1):118-26. (Pubitemid 34747532)
31. Pavese P, Bonadona A, Beaubien J, et al. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Can J Anaesth. 2005;52(1): 26-9. (Pubitemid 40361015)
32. Porte RJ, Caldwell SH. The role of recombinant factor VIIa in liver transplantation. Liver Transpl. 2005;11(8):872-4. (Pubitemid 41122441)
33. Shami VM, Caldwell SH, Hespenheide EE, et al. Recombinant activated factorVII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl. 2003;9(2):138-43. (Pubitemid 36204564)
34. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127-37. (Pubitemid 351679599)
35. Munoz SJ, Ballas SK, Moritz MJ, et al. Perioperative management of fulminant and subfulminant hepatic failure with therapeutic plasmapheresis. Transplant Proc. 1989;21(3):3535-6. (Pubitemid 20145195)
36. Munoz SJ, Moritz MJ, Bell R, et al. Factors associated with severe intracranial hypertension in candidates for emergency liver transplantation. Transplantation. 1993;55(5):1071-4. (Pubitemid 23150737)
37. Robertson CS, Valadka AB, Hannay HJ, et al. Prevention of secondary ischemic insults after severe head injury. Crit Care Med. 1999;27(10):2086-95. (Pubitemid 29508318)
38. Contant CF, Valadka AB, Gopinath SP, et al. Adult respiratory distress syndrome: a complication of induced hypertension after severe head injury. J Neurosurg. 2001;95(4):560-8. (Pubitemid 33031416)
39. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma. 2007;24(Suppl 1):S59-64.
40. Aiyagari V, Deibert E, Diringer MN. Hypernatremia in the neurologic intensive care unit: how high is too high? J Crit Care. 2006;21(2):163-72. (Pubitemid 43850184)
41. Caraceni P, Van Thiel DH. Acute liver failure. Lancet. 1995; 345(8943):163-9.
42. Munoz SJ. Difficult management problems in fulminant hepatic failure. Semin Liver Dis. 1993;13(4):395-413. (Pubitemid 24007143)
43. Sen S, Rose C, Ytrebo LM, et al. Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med. 2006;34(1):158-64. (Pubitemid 43032393)
44. Stravitz RT, Larsen FS. Therapeutic hypothermia for acute liver failure. Crit Care Med. 2009;37(7 Suppl):S258-64.
45. Jalan R. Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure. Neurochem Int. 2005;47(1-2): 78-83. (Pubitemid 40848696)
46. Jalan R, Davies NA, Olde Damink SW. Hypothermia for the management of intracranial hypertension in acute liver failure. Metab Brain Dis. 2002;17(4):437-44. (Pubitemid 36204772)
47. Jalan R, Olde Damink SW. Hypothermia for the management of intracranial hypertension in acute liver failure. Curr Opin Crit Care. 2001;7(4):257-62. (Pubitemid 32868475)
48. Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation. 2003;75(12):2034-9. (Pubitemid 36793288)
49. Jalan R, Olde Damink SW, Deutz NE, et al. Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia. Hepatology. 2001;34(1):50-4. (Pubitemid 32591482)
50. Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology. 2004;127(5):1338-46. (Pubitemid 39457760)
51. Jalan R, Rose C. Hypothermia in acute liver failure. Metab Brain Dis. 2004;19(3-4):215-21. (Pubitemid 39361183)
52. Jalan R, OD SW, Deutz NE, et al. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet. 1999;354(9185):1164-8. (Pubitemid 29460446)
53. Stadlbauer V, Jalan R. Acute liver failure: liver support therapies. Curr Opin Crit Care. 2007;13(2):215-21. (Pubitemid 46328338)
54. Laffey JG, Kavanagh BP. Hypocapnia.NEngl J Med. 2002;347(1): 43-53.
55. Felipo V, Butterworth RF. Mitochondrial dysfunction in acute hyperammonemia. Neurochem Int. 2002;40(6):487-91. (Pubitemid 34159149)
56. Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology. 2000;32(3):536-41.
57. Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controlled clinical trial. J Hepatol. 2004;41(1):89-96. (Pubitemid 39005158)
58. Claassen J, Mayer SA, Kowalski RG, et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62(10):1743-8. (Pubitemid 38661728)
59. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology. 2000;54(2):340-5. (Pubitemid 30078063)
60. Oddo M, Carrera E, Claassen J, et al. Continuous electroencephalography in the medical intensive care unit. Crit Care Med. 2009;37(6):2051-6.
61. LeeWM,Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137(3):856-64. 864 e851.
62. McKenzie TJ, Lillegard JB, Nyberg SL. Artificial and bioartificial liver support. Semin Liver Dis. 2008;28(2):210-7. (Pubitemid 351632960)
63. Ferraz-Neto BH, Moraes-Junior JM, Hidalgo R, et al. Total hepatectomy and liver transplantation as a two-stage procedure for toxic liver: case reports. Transplant Proc. 2008;40(3):814-6. (Pubitemid 351608647)
64. Taylor RM, Davern T, Munoz S, et al. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology. 2006;44(6):1589-97. (Pubitemid 44953664)
65. Fontana RJ. Acute liver failure including acetaminophen overdose. Med Clin North Am. 2008;92(4):761-94. viii. (Pubitemid 351822355)
66. Mindikoglu AL, Magder LS, Regev A. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl. 2009;15(7):719-29.
67. O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989; 97(2):439-45. (Pubitemid 19192181)
68. Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8(9):851-8. (Pubitemid 35012300)
69. Kremers WK, van IJperen M, Kim WR, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/ UNOS status 1 patients. Hepatology. 2004;39(3):764-9. (Pubitemid 38337656)
70. Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007;45(3):789-96. (Pubitemid 46450630)
71. Bernal W, Donaldson N, Wyncoll D, et al. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet. 2002;359(9306):558-63. (Pubitemid 34178437)
72. Katoonizadeh A, Decaestecker J, Wilmer A, et al. MELD score to predict outcome in adult patients with non-acetaminopheninduced acute liver failure. Liver Int. 2007;27(3):329-34. (Pubitemid 46416622)
73. Moller HJ, Gronbaek H, Schiodt FV, et al. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol. 2007;47(5):671-6. (Pubitemid 47503425)